There are 2867 resources available
346P - Influence of single nucleotide polymorphisms in genes involved in capecitabine activation pathway on treatment toxicity in patients with colorectal cancer
Presenter: YASMIN CURA
Session: Poster session 07
347P - Prognostic impact of signet ring cell proportion in colorectal cancer patients with peritoneal metastases
Presenter: Vahan Kepenekian
Session: Poster session 07
348P - Prediction of sensitivity to anti-EGFR inhibitors in salvage-line treatment for metastatic colorectal cancer using a modified MethyLight assay
Presenter: Kota Ouchi
Session: Poster session 07
350P - Postoperative histopathological, clinical and molecular risk score for patients with colorectal liver metastases
Presenter: Berta Martin Cullell
Session: Poster session 07
351P - Prevalence of ERBB alterations in colorectal cancer patients using genomic profiling
Presenter: Madappa Kundranda
Session: Poster session 07
352P - Mutations of SMAD4 and FBXW7 predict poor outcome in TP53-driven metastatic colorectal cancer
Presenter: Sara Lahoz
Session: Poster session 07
353P - Loss of CDX2 and high COX2 (PTGS2) expression in stage IV colorectal cancer
Presenter: Alvaro Caldas
Session: Poster session 07
354P - NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin (NUFOX) or irinotecan (NUFIRI) in patients with advanced colorectal cancer (CRC) (NuTide:302)
Presenter: Andrew Coveler
Session: Poster session 07